Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
SynapCon
SynapCon GmbH is a digital health technology company focused on accelerating clinical trials for drugs, medical devices, and IVDs through a fully integrated software suite. Their platform combines…
SynapCon
SynapCon GmbH is a digital health technology company focused on accelerating clinical trials for drugs, medical devices, and IVDs through a fully integrated software suite. Their platform combines…
TL;DR
Founded: May 2021
Headquarters: Frankfurt am Main, Germany
Product: EasyClin®—integrated digital clinical trials suite
Focus: Accelerating clinical trials for biotech, medtech, pharma, and IVD
Funding signal: Seed round closed March 2023 (amount undisclosed)
Company Overview
Problem Domain
Clinical trial inefficiency and paper‑based workflows in drug, medical device, and IVD development.
Founded
2021
Industry
Digital health / Clinical trials software
Funding Track Record
Crunchbase lists a Seed round closed March 2023; public profiles do not disclose amount or investor names.
Investor Signal
“Public sponsorship from two German federal ministries (Federal Ministry of Economic Affairs & Energy; Federal Ministry of Education and Research) and an investor contact provided by the company (invest@synapcon.com).”